220 related articles for article (PubMed ID: 6965373)
1. The Sézary cell in the blood of patients with mycosis fungoides.
Winkelmann RK; Hoagland HC
Dermatologica; 1980; 160(2):73-9. PubMed ID: 6965373
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.
Feng B; Jorgensen JL; Jones D; Chen SS; Hu Y; Medeiros LJ; Wang SA
Mod Pathol; 2010 Feb; 23(2):284-95. PubMed ID: 19935642
[TBL] [Abstract][Full Text] [Related]
3. Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin.
Meijer CJ; van der Loo EM; van Vloten WA; van der Velde EA; Scheffer E; Cornelisse CJ
Cancer; 1980 Jun; 45(11):2864-71. PubMed ID: 6966534
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
Bachelez H
Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
[No Abstract] [Full Text] [Related]
5. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
Safai B
Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
[No Abstract] [Full Text] [Related]
6. Sézary cells in ascitic fluid.
Vernon SE; Rosenthal DL
Acta Cytol; 1979; 23(5):408-11. PubMed ID: 316632
[TBL] [Abstract][Full Text] [Related]
7. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.
Pulitzer MP; Horna P; Almeida J
Cytometry B Clin Cytom; 2021 Mar; 100(2):132-138. PubMed ID: 32516521
[TBL] [Abstract][Full Text] [Related]
8. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.
Oka T; Miyagaki T; Takahashi N; Nakajima R; Kamijo H; Suga H; Asano Y; Sugaya M; Sato S
J Invest Dermatol; 2018 Oct; 138(10):2286-2288. PubMed ID: 29605670
[No Abstract] [Full Text] [Related]
9. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
[TBL] [Abstract][Full Text] [Related]
10. Screening tests for Sezary cells in cutaneous T-cell lymphomas.
Newton JA; Guthrie DL; Westwood NB; Pearson TC; Camplejohn RS; Smith N
Clin Lab Haematol; 1986; 8(2):109-14. PubMed ID: 3488168
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: International guidelines for assay characteristics.
Horna P; Wang SA; Wolniak KL; Psarra K; Almeida J; Illingworth AJ; Johansson U; Craig FE; Torres R
Cytometry B Clin Cytom; 2021 Mar; 100(2):142-155. PubMed ID: 32319723
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides.
Gaeke ME; Variakojis D; Sweet DL
Curr Probl Cancer; 1981 Sep; 6(3):1-39. PubMed ID: 7285618
[No Abstract] [Full Text] [Related]
13. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Circulating Sézary cells. A new preparatory method for their identification and enumeration.
Fletcher V; Zackheim HS; Beckstead JH
Arch Pathol Lab Med; 1984 Dec; 108(12):954-8. PubMed ID: 6239604
[TBL] [Abstract][Full Text] [Related]
16. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
[TBL] [Abstract][Full Text] [Related]
17. Increased serum neopterin levels in mycosis fungoides and Sézary syndrome.
Hamerlinck FF; Toonstra J; van Vloten WA
Br J Dermatol; 1999 Dec; 141(6):1136-7. PubMed ID: 10722267
[No Abstract] [Full Text] [Related]
18. Sézary syndrome and mycosis fungoides flow cytometric evaluation: The clinicians' perspective.
Guitart J
Cytometry B Clin Cytom; 2021 Mar; 100(2):129-131. PubMed ID: 32017375
[TBL] [Abstract][Full Text] [Related]
19. It is time to adopt a multicolor immunophenotyping approach to evaluate blood for Sézary syndrome and mycosis fungoides.
Craig FE
Cytometry B Clin Cytom; 2021 Mar; 100(2):125-128. PubMed ID: 32083391
[No Abstract] [Full Text] [Related]
20. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]